Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)
Status:
Not yet recruiting
Trial end date:
2029-03-31
Target enrollment:
Participant gender:
Summary
This is a pragmatic phase III, randomized, blinded, double placebo-controlled, three-arm
trial of elderly patients following cardiac surgery to assess the relationship between
nighttime intravenous (IV) and sublingual dexmedetomidine on postoperative delirium and
functional outcomes after surgery.